Omena, a Paris-based FemTech startup, has secured an €800K seed investment, marking its second significant fundraising effort following a €400K pre-seed round in 2021. The company focuses on providing comprehensive support and services to menopausal women through its app. The funding round drew contributions from business angels and family offices, including prominent returning investors such as Alexandre Lebrun, founder of AI healthtech…
Diva’Me, a femtech company co-founded by Prashant and Nadine Audi, has raised $1 million in pre-seed funding led by Verde. Based in Dubai, the company is committed to revolutionizing women’s health by advancing societal norms surrounding menstruation and offering innovative, technology-driven solutions. Central to Diva’Me’s mission is the development of an AI-based personalized counseling app. This forthcoming app is designed to connect…
3Daughters, a clinical development company dedicated to advancing healthcare for women, has successfully closed over $2 million in the initial phase of its seed funding round. The round, led by Thairm Bio and supported by the Argosy Foundation, Wexford Science and Technology, UMass Amherst, and other undisclosed investors, marks a significant step in the company’s mission to develop a new intrauterine device…
Vyld, a Berlin-based profit-for-purpose company, has successfully completed a significant seed funding round, securing a seven-figure sum to advance its mission of developing sustainable, ocean-friendly products. The funding round, backed by a blend of government funds, the EU, and a cohort of angel investors and venture funds, reflects a growing interest in sustainable innovations in the women’s health sector. Founded by Ines…
Granata Bio, a biopharma company specializing in fertility medications, has announced the closure of a $14 million Series A funding round. Led by GV (Google Ventures), this funding round includes significant contributions from CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio, and others. The investment aims to accelerate the development of Granata Bio’s fertility biopharma pipeline, addressing a critical gap…
The neurodevelopmental condition known as attention-deficit/hyperactivity disorder (ADHD) is massive; according to the renowned ADHD authority, Dr. Russell A. Barkley, Ph.D., 13 million American adults (4-5%) deal with its impacts every day. ADHD may make it difficult to regulate emotions and complete everyday tasks at work and at home. It often leads to anxiety, depression, relationship problems, personal/professional stress and disruption, substance abuse, and…
Health In Her HUE, the digital health platform, specifically designed for Black women and women of color, recently announced the closing of a a $3M seed funding round. This investment is aimed at enhancing the company’s growth by expanding its talent pool and developing new programs and products. The funding round was spearheaded by Seae Ventures and saw participation from several notable…
Heranova Lifesciences has announced the completion of a $13.5M seed and seed+ financing round to develop and offer integrated women’s health solutions. The fresh funds will go towards the launch of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis. Institutional investors including Pivotal bioVenture Partners China, Sinovation Ventures, Emerging Technology Partners, and Triwise Capital…
